Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research

Rui‐Hua Xu(Sun Yat-sen University)
Signal Transduction and Targeted Therapy
November 3, 2025
Cited by 4


Related Papers